Researchers looked at several studies involving women who experienced repeated issues getting pregnant, a condition known as unexplained recurrent implantation failure. They specifically examined the use of platelet-rich plasma (PRP) injected into the uterus as a potential extra treatment.
The review found that using PRP was linked to improvements in three key areas: the rate of embryo implantation, the rate of clinical pregnancies, and the rate of live births. These results suggest that the treatment could be a helpful addition for women struggling with these specific fertility challenges.
However, it is important to note that the quality of the evidence is currently low. Because many of the studies were small or lacked detailed data, the actual impact of the treatment is not fully certain. Patients should discuss these findings with their doctors to see if this option fits their specific medical needs.
Common questions
What is the role of platelet-rich plasma in fertility?
Platelet-rich plasma (PRP) is being studied as a potential extra treatment for women with unexplained recurrent implantation failure. The review found that using this treatment was linked to improvements in embryo implantation, clinical pregnancy rates, and live birth rates.
Is the evidence for this treatment strong?
The current evidence is considered low quality. Because of the limited data available from the studies reviewed, it is not yet certain how much of an effect the treatment has. It is currently seen as a promising but early option.
Who specifically can benefit from this treatment?
This finding specifically concerns women who have experienced unexplained recurrent implantation failure (RIF). These are cases where embryos fail to implant in the uterus despite standard treatments. You should talk to your doctor about these results.
